Two of 5 mice had complete regression of their tumors; these animals had ongoing antitumor responses after the cessation of anti–PD-1 therapy and upon later tumor rechallenge, which also was significantly improved compared with untreated CATT7 tumors (Figure 2, H and I). Here, PDCD1 is linked to neoplasm.